secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2025-01-23T23:59:59+00:00
Accession:  0001601485-25-000009
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elicio posts corporate deck; no extractable clinical/financial data in filing text
--------------------------------------------------------------------------------

- Corporate presentation posted on company website dated January 23, 2025.
- Presentation title: 'Targeting the Lymph Nodes to AMPlify Immunotherapy'.
- No specific pipeline, financial, or milestone data available from the provided exhibit text.
- Standard forward-looking statement disclaimers and market data cautions included.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000160148525000009/0001601485-25-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000160148525000009/angn-20250123.htm
  HTML page:      https://secwatch.observer/filing/0001601485-25-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer